4//SEC Filing
Dick Evan G. 4
Accession 0001179110-21-009608
CIK 0001842952other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 5:29 PM ET
Size
6.9 KB
Accession
0001179110-21-009608
Insider Transaction Report
Form 4
Dick Evan G.
SVP of R&D
Transactions
- Conversion
Series Seed Preferred Stock
2021-10-22−26,587→ 0 total→ Common Stock (26,587 underlying) - Conversion
Common Stock
2021-10-22+26,587→ 87,139 total
Footnotes (3)
- [F1]Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]Includes 39,659 restricted stock units which fully vest on February 24, 2023.
- [F3]Fully vested.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001862116
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 5:29 PM ET
- Size
- 6.9 KB